Cite
HARVARD Citation
Manaka, D. et al. (n.d.). P-224Analysis of clinical outcomes of two antiEGFR antibodies, cetuximab and panitumumab, in the 1st line chemotherapy of RAS wild metastatic colorectal cancer, by neutrophil-to-lymphocyte ratio (NLR) kinetics. Annals of oncology. p. . [Online].